[go: up one dir, main page]

AR040562A1 - Capsulas para la higene bucal - Google Patents

Capsulas para la higene bucal

Info

Publication number
AR040562A1
AR040562A1 AR20030102526A ARP030102526A AR040562A1 AR 040562 A1 AR040562 A1 AR 040562A1 AR 20030102526 A AR20030102526 A AR 20030102526A AR P030102526 A ARP030102526 A AR P030102526A AR 040562 A1 AR040562 A1 AR 040562A1
Authority
AR
Argentina
Prior art keywords
capsules
microcapsules
microcapsule
capsule
oral
Prior art date
Application number
AR20030102526A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR040562A1 publication Critical patent/AR040562A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Cápsulas o microcápsulas de gelatina blanda. Más particularmente, se refiere a cápsulas o microcápsulas para la higiene bucal que proporcionan actividad biológica o terapéutica mejorada. Reivindicación 1: Una cápsula o microcápsula caracterizada porque comprende a) una envuelta; y b) un núcleo, que comprende: i) al menos un aceite esencial terapéutica o biológicamente activo; y ii) menos que aproximadamente 20 % en peso de la cápsula o microcápsula total, de un aceite fijo.
AR20030102526A 2002-07-16 2003-07-14 Capsulas para la higene bucal AR040562A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39640102P 2002-07-16 2002-07-16

Publications (1)

Publication Number Publication Date
AR040562A1 true AR040562A1 (es) 2005-04-13

Family

ID=30116024

Family Applications (1)

Application Number Title Priority Date Filing Date
AR20030102526A AR040562A1 (es) 2002-07-16 2003-07-14 Capsulas para la higene bucal

Country Status (14)

Country Link
US (1) US20040013723A1 (es)
EP (1) EP1523304A1 (es)
JP (1) JP3884457B2 (es)
AR (1) AR040562A1 (es)
AU (1) AU2003244988A1 (es)
BR (1) BR0312683A (es)
CA (1) CA2488923A1 (es)
GT (1) GT200300145A (es)
MX (1) MXPA04011834A (es)
PA (1) PA8576301A1 (es)
PE (1) PE20040105A1 (es)
TW (1) TW200401652A (es)
WO (1) WO2004006896A1 (es)
ZA (1) ZA200409640B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409329A (pt) * 2003-04-14 2006-04-25 Fmc Corp processo para fabricar pelìculas de gel termorreversìveis, homogêneas, pelìcula homogênea, termorreversìvel, de sólidos altos, umidade baixa, processo para fabricar cápsulas moles, cápsulas moles, processo para fabricar uma forma de dosagem sólida, forma sólida, processo para preparar uma sistema de liberação de pelìcula de gel homogênea, e, sistema de liberação
US7816341B2 (en) * 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
US20050008677A1 (en) * 2003-04-14 2005-01-13 Fmc Corporation Delivery system of homogeneous, thermoreversible gel film containing kappa-2 carrageenan
CN1882353B (zh) * 2003-11-19 2011-04-20 明治制果株式会社 催涎剂和混合该催涎剂的口腔用组合物以及食品组合物
WO2007014445A1 (en) * 2005-08-02 2007-02-08 Miv Therapeutics Inc. Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
ITMI20052342A1 (it) * 2005-12-06 2007-06-07 Perfetti Van Melle Spa Formulazioni per l'igiene orale in forma di capsule
CN101466347A (zh) * 2006-06-13 2009-06-24 吉万奥丹股份有限公司 包封组合物
US8178483B2 (en) * 2007-03-30 2012-05-15 Colgate-Palmolive Company Polymeric encapsulates having a quaternary ammonium salt and methods for producing the same
AU2008237246B2 (en) * 2007-04-05 2014-06-05 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
US8900629B2 (en) 2007-04-05 2014-12-02 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
US9332774B2 (en) 2007-06-27 2016-05-10 Bunge Oils, Inc. Microencapsulated oil product and method of making same
TWI404544B (zh) * 2008-08-11 2013-08-11 Colgate Palmolive Co 含珠粒之口腔保健組成物
DE102010022174A1 (de) * 2010-05-12 2011-11-17 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Darreichungsformen für Cineol
WO2012087280A2 (en) * 2010-12-20 2012-06-28 Colgate-Palmolive Company Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier
EP2663294B1 (en) 2011-01-11 2015-09-30 Capsugel Belgium NV New hard capsules comprising pullulan
EP2801263B1 (de) * 2013-05-09 2021-04-14 Symrise AG Verfahren zur Herstellung einer kühlende Zusammensetzung in Form eines Granulats
CN104621714B (zh) * 2014-12-04 2018-01-05 湖北中烟工业有限责任公司 一种提高脆性的烟用添加剂滴丸及其制备方法
CN105603765A (zh) * 2016-02-25 2016-05-25 苏州三和开泰花线织造有限公司 一种玫瑰精油微胶囊整理剂的制备方法及其应用
AU2018253392B2 (en) 2017-04-14 2023-11-02 Capsugel Belgium Nv Process for making pullulan
AU2018251256B2 (en) 2017-04-14 2023-10-05 Capsugel Belgium Nv Pullulan capsules
CN112237240A (zh) * 2019-07-16 2021-01-19 重庆味来香生物科技有限公司 缓释肠溶微囊植物精油制作技术
CN112022738B (zh) * 2020-09-11 2022-09-13 华熙生物科技股份有限公司 含透明质酸的口腔黏膜保护爆浆胶囊、制法及其应用
DE102024122280A1 (de) * 2024-08-05 2026-02-05 Christian Reindl Kapsel, Verfahren zum Herstellen einer Kapsel, Verfahren zum Herstellen eines ätherischen Aerosols und Blister mit der Kapsel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435440A (en) * 1976-01-08 1984-03-06 Tate & Lyle Limited Sweeteners
US4945087A (en) * 1988-03-31 1990-07-31 Warner-Lambert Company Taste masking of thymol
US5370864A (en) * 1993-06-29 1994-12-06 The Procter & Gamble Company Breath protection microcapsules
US5912007A (en) * 1996-02-29 1999-06-15 Warner-Lambert Company Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
ES2134743B1 (es) * 1998-02-06 2000-05-01 Biocosmetics Sl Composicion para el tratamiento de la halitosis.
ITMI981542A1 (it) * 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
US6238648B1 (en) * 1999-03-25 2001-05-29 The Procter & Gamble Company Anti-caries oral care compositions and their methods of use
CN1102397C (zh) * 2000-03-01 2003-03-05 山东绿叶制药股份有限公司 当归油软胶囊及其制备工艺
EP1399120A1 (en) * 2001-06-11 2004-03-24 Warner-Lambert Company LLC Breath protection microcapsules

Also Published As

Publication number Publication date
PE20040105A1 (es) 2004-02-27
GT200300145A (es) 2004-03-17
CA2488923A1 (en) 2004-01-22
AU2003244988A1 (en) 2004-02-02
PA8576301A1 (es) 2004-05-26
BR0312683A (pt) 2005-04-26
MXPA04011834A (es) 2005-03-31
JP2006500084A (ja) 2006-01-05
TW200401652A (en) 2004-02-01
WO2004006896A1 (en) 2004-01-22
JP3884457B2 (ja) 2007-02-21
US20040013723A1 (en) 2004-01-22
ZA200409640B (en) 2005-10-14
EP1523304A1 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
AR040562A1 (es) Capsulas para la higene bucal
ES2530719T3 (es) Formulaciones de oxicodona para ser administradas una vez al día
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
CO5570656A2 (es) Liberacin controlada de una sustancia activa a un entorno rico en grasa
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
ES2195220T3 (es) Acidos sulfonilaminocarboxilicos.
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
ES2165640T3 (es) Acidos diaminocarboxilicos sustituidos.
ES2159591T3 (es) Composicion de liberacion controlada.
ECSP045102A (es) Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
PE8298A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol para administracion oral
CA2273420A1 (fr) Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale
ECSP044986A (es) Composicion farmaceutica que comprende lumiracoxib
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
BR0314787A (pt) Forma de dosagem de liberação modificada
AR040378A1 (es) Formulaciones farmaceuticas de liberacion controlada
AR039977A1 (es) Composicion a base de diclofenac para el tratamiento topico de afecciones de la cavidad orofaringea
AR041573A1 (es) Uso de ihidromidazolonas para la preparacion demedicamentos para caninos
BR0308795A (pt) Amidas do ácido sulfamico
AR039162A1 (es) Formulaciones de venlafaxina de liberacion extendida
SE0003092D0 (sv) New Use

Legal Events

Date Code Title Description
FB Suspension of granting procedure